Contributors
Juristat #4 Overall Rank
Contact the Docs
Foreign Correspondents
Recent Posts
- Supreme Court Denies Certiorari in Cellect v. Vidal
- In re Cellect in View of Supreme Court's "Long Conference" – Part II
- In re Cellect in View of Supreme Court's "Long Conference"
- Novartis Pharma AG v. Regeneron Pharmaceuticals, Inc. (Fed. Cir. 2024)
- Astellas Pharma, Inc. v. Sandoz Inc. (Fed. Cir. 2024)
- Wisconsin Alumni Research Foundation v. Apple Inc. (Fed. Cir. 2024)
- Special Committee's Suspension Recommendation Adopted by Federal Circuit
- Natera, Inc. v. NeoGenomics Laboratories, Inc. (Fed. Cir. 2024)
- Andersen v. Stability AI: Defendants' Motion to Dismiss Narrows the Case, But Only Slightly
- Ryan LLC v. FTC: Texas Federal Court Strikes Down FTC's Prohibition on Non-Competes
Disclaimer
- "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat #8 Overall Rank
- Powered By Invesp
« Medtronic, Inc. v. Teleflex Life Sciences Ltd. (Fed. Cir. 2023) | Main | College Football's Latest Controversy: NCAA IP-Like "Sign Stealing" Rules Not Ready for Big Data or AI »
November 23, 2023
The comments to this entry are closed.
October 2024
Categories
- Artificial Intelligence (19)
- Best Mode (2)
- Biosimilars (247)
- Biotech/Pharma Business (175)
- Biotech/Pharma News (277)
- Board of Patent Appeals and Interferences (12)
- Claim Construction (104)
- Conferences & CLE's (2977)
- Copyright (4)
- Court Report (507)
- Damages (37)
- Definiteness (26)
- District Court (222)
- Double Patenting (40)
- Enablement (52)
- Federal Circuit (1017)
- Food and Drug Administration (109)
- Hatch-Waxman (93)
- Inequitable Conduct (52)
- Infringement - Contributory or Induced (28)
- Infringement - Literal or DOE (91)
- Injunction (34)
- International IP (297)
- Inventorship (17)
- Licensing (129)
- Media Commentary (71)
- Miscellaneous (168)
- News from Abroad (102)
- Novelty (73)
- Obviousness (233)
- Patent Exhaustion (3)
- Patent Legislation (312)
- Patent Litigation (217)
- Patent Office Rules & Procedures (827)
- Patent Profiles (104)
- Patent Prosecution (99)
- Patent Prosecution - International (26)
- Patent Research (4)
- Patent Trial and Appeal Board (369)
- Patentable Subject Matter (644)
- Personalized Medicine (5)
- Post-Grant Proceedings (158)
- PTAB Report (9)
- Study/Report (7)
- Supreme Court (265)
- Tools (5)
- Trade Secrets (13)
- Utility (4)
- Venue (11)
- Written Description (88)
Patent Resources
Patent Search
- Patent Search
Patent Blogs & Sites
- 717 Madison Place
- America-Israel Patent Law
- Anticipate This!
- BlawgIT
- Chicago IP Litigation Blog
- FedCircuitBlog
- Global Patent Quality
- Innovation Alliance
- Intellectual Property Watch
- IP Dragon
- IPcopy
- McCabe Ali LLP
- IPWatchdog.com
- Life Science IP
- Orange Book Blog
- Patent Blurb
- Patently-O
- Patentology
- Patents4Life
- Reexamination Center
- Intellepedia – IP News Center
- SPICY IP
Comments